Randomized trials comparing multi-vessel percutaneous coronary intervention to coronary artery bypass grafting (CABG)
have demonstrated the long-term superiority of CABG in diabetic patients. Benefits include improved survival, fewer recurrent myocardial
infarctions and a lower risk of the need for repeat intervention. The focus of this review article is to review the contemporary management
of diabetic patients with multi-vessel coronary artery disease.
Keywords: Percutaneous coronary intervention, Drug eluting stents, Coronary artery bypass grafting, Diabetes mellitus, Coronary artery
disease, Revascularization, Survival.
Rights & PermissionsPrintExport